Suvoda's IRT Software Recognized as a Leader in Everest Group's PEAK Matrix
Suvoda, a global technology firm specializing in clinical trials, has recently achieved a significant milestone by being named a leader in the Everest Group's PEAK Matrix® for Interactive Response Technology (IRT), also referred to as Randomization and Trial Supply Management (RTSM). This accolade marks a pivotal moment in the field of clinical trial management, reflecting Suvoda's innovative approach and market impact.
The Everest Group's PEAK Matrix® is a rigorous evaluation system that assesses technology providers based on their market influence, vision, and delivery capabilities. The evaluation process involves direct client surveys, providing insights into vendors' actual performance and user experiences. By being recognized as a leader, Suvoda underscores its robust market acceptance, technical innovation, and the effectiveness of its IRT solutions.
Nisarg Shah, Practice Leader at the Everest Group, mentioned, "Suvoda specializes in managing highly complex, multi-arm studies, enabled by its low-code/no-code platform, virtual partition framework, and extensive integration network. The system's modular architecture, flexible study configuration, and ongoing investment in AI-driven automation position it strongly within the PEAK Matrix for RTSM products in the Life Sciences Assessment for 2025."
Expressing their gratitude for the recognition, Jagath Wanninayake, CEO of Suvoda commented, "We are honored to be identified as a leader by the Everest Group. This acknowledgment confirms that Suvoda IRT provides unparalleled capabilities and speed for randomization and supply management in complex clinical trials. It also reflects our ongoing commitment to evolving our platform by integrating IRT with our broader product range to manage the most critical and time-sensitive aspects of each study for our clients."
Suvoda IRT functions as the "command center" for clinical trial logistics, enabling sponsors, Contract Research Organizations (CROs), and trial sites to deliver the right treatment to the right patient at the right time. Built on a configurable architecture, Suvoda IRT supports even the most intricate protocols while offering real-time inventory transparency and proactive resupply capabilities. The system's adaptability allows for swift responses to mid-study changes, supported by several awarded patents that recognize the company's innovation.
By changing the landscape of clinical trial experiences for sponsors, CROs, trial sites, and patients, Suvoda IRT sets new industry standards. The platform streamlines the entire trial journey, making it more intuitive for users. To further enhance usability, Suvoda has recently introduced Sofia, an AI assistant designed to simplify tasks for supply chain managers. Sofia assists with data queries, inventory monitoring, visit schedule reviews, and data visualization creation – all through an interactive interface. Furthermore, the system provides real-time analytics via pre-set and ad-hoc reports, allowing teams to make informed decisions swiftly.
The Everest Group's report on Suvoda IRT highlights not only the strength of the software but also the company's commitment to advancing clinical trial technology. Suvoda, which is merging with Greenphire, a leading clinical trial financial management and patient support tool provider, continues to push the boundaries of what's possible in clinical research. This combination aims to equip sponsors and CROs with connected, actionable software solutions and industry-leading services that will facilitate transformative studies, even in the most time-critical and mission-sensitive scenarios.
For further insights into Suvoda's innovative capabilities and their ranking in the Everest Group report, check their official website at suvoda.com and follow them on LinkedIn for more updates.
The Everest Group's PEAK Matrix® is a rigorous evaluation system that assesses technology providers based on their market influence, vision, and delivery capabilities. The evaluation process involves direct client surveys, providing insights into vendors' actual performance and user experiences. By being recognized as a leader, Suvoda underscores its robust market acceptance, technical innovation, and the effectiveness of its IRT solutions.
Nisarg Shah, Practice Leader at the Everest Group, mentioned, "Suvoda specializes in managing highly complex, multi-arm studies, enabled by its low-code/no-code platform, virtual partition framework, and extensive integration network. The system's modular architecture, flexible study configuration, and ongoing investment in AI-driven automation position it strongly within the PEAK Matrix for RTSM products in the Life Sciences Assessment for 2025."
Expressing their gratitude for the recognition, Jagath Wanninayake, CEO of Suvoda commented, "We are honored to be identified as a leader by the Everest Group. This acknowledgment confirms that Suvoda IRT provides unparalleled capabilities and speed for randomization and supply management in complex clinical trials. It also reflects our ongoing commitment to evolving our platform by integrating IRT with our broader product range to manage the most critical and time-sensitive aspects of each study for our clients."
Suvoda IRT functions as the "command center" for clinical trial logistics, enabling sponsors, Contract Research Organizations (CROs), and trial sites to deliver the right treatment to the right patient at the right time. Built on a configurable architecture, Suvoda IRT supports even the most intricate protocols while offering real-time inventory transparency and proactive resupply capabilities. The system's adaptability allows for swift responses to mid-study changes, supported by several awarded patents that recognize the company's innovation.
By changing the landscape of clinical trial experiences for sponsors, CROs, trial sites, and patients, Suvoda IRT sets new industry standards. The platform streamlines the entire trial journey, making it more intuitive for users. To further enhance usability, Suvoda has recently introduced Sofia, an AI assistant designed to simplify tasks for supply chain managers. Sofia assists with data queries, inventory monitoring, visit schedule reviews, and data visualization creation – all through an interactive interface. Furthermore, the system provides real-time analytics via pre-set and ad-hoc reports, allowing teams to make informed decisions swiftly.
The Everest Group's report on Suvoda IRT highlights not only the strength of the software but also the company's commitment to advancing clinical trial technology. Suvoda, which is merging with Greenphire, a leading clinical trial financial management and patient support tool provider, continues to push the boundaries of what's possible in clinical research. This combination aims to equip sponsors and CROs with connected, actionable software solutions and industry-leading services that will facilitate transformative studies, even in the most time-critical and mission-sensitive scenarios.
For further insights into Suvoda's innovative capabilities and their ranking in the Everest Group report, check their official website at suvoda.com and follow them on LinkedIn for more updates.
Topics Business Technology）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.